Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Paring Down Essential Medicines List In Sweeping Health System Reforms

This article was originally published in PharmAsia News

Executive Summary

[Editor's note: This is part three in a new series on China's wide-ranging plans to reform the country's health system, including its hospitals, insurance schemes, and access to medicines. Part one in the series appeared in PharmAsia News Oct. 30, 2008, and part two appeared Nov. 13, 2008.]
Advertisement

Related Content

China Needs To Balance Equal Access To Affordable Medicines With Sharpening Focus On Innovative Drugs In Mapping Out Future, Say Leaders At DIA Conference
Powerful Chinese Government Commission Set To Issue Price Caps For Essential Drug List Medicines
Taiwan's Biobusiness Asia Conference Draws Big Pharma Looking For Perfect Biotech Match
Will Being On China’s New Essential Drugs List Be A Boon Or A Bane?
Will Placement On China's New Essential Drugs List Bring Boon Or Bane? Pharma Execs Debate The Issue
China Debates Changes In Government Price Ceilings On Drugs As Part Of Health System Reforms
China’s 2009 Regulatory Changes Affect Drug, API And Device Makers
China’s 2009 Regulatory Changes Will Affect Makers of Drugs, APIs and Devices
China’s Supreme Court States Doctors Accepting Bribes Can Be Criminally Prosecuted
China Set To Launch Sweeping Health System Reforms, Aimed In Part At Reversing Stratified Access To Medicine, Hospitals, Insurance
Advertisement
UsernamePublicRestriction

Register

SC067576

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel